Featured News
-
ACLA Outlines Key Changes Required to Protect Beneficiaries’ Access to Cancer Testing
Washington, D.C. – Recent proposals from the Centers for Medicare & Medicaid Services (CMS) would have widespread, detrimental consequences on cancer care for millions of Medicare beneficiaries, specifically for patients with a genetic predisposition for breast and ovarian cancer. In new comments submitted to the agency, the American Clinical Laboratory Association (ACLA) called on CMS to remove barriers to coverage of germline tests usingContinue Reading »... -
As Seniors’ Lab Benefits Hang In The Balance, Leading Stakeholder Groups Urge Congress To Pass LAB Act In End-of-Year Legislation
WASHINGTON, D.C.— In a new letter to Congressional leadership, more than 33 stakeholder groups are urging lawmakers to pass commonsense, bipartisan reforms that would take steps to mitigate the ongoing harm facing more than 53 million seniors who depend on vital clinical laboratory services. The letter reinforces the urgent need for Congress to immediately advance H.R. 3584 – The Laboratory Access for Beneficiaries (LAB)Continue Reading »... -
ACLA Comments on NGS Proposed Decision Memo
... -
ACLA Files A Motion for Summary Judgment Against HHS In ACLA v. Azar
Washington, D.C. — Following a favorable decision on a jurisdictional question issued by the U.S. Court of Appeals for the D.C. Circuit, the American Clinical Laboratory Association (ACLA) has filed a motion for summary judgment before the U.S. District Court for the District of Columbia challenging the flawed implementation of the Protecting Access to Medicare Act (PAMA) in the final rule promulgated by the U.S. DepartmentContinue Reading »... -
ACLA Comments on CY 2020 OPPS Proposed Rule
... -
ACLA Comments on CY 2020 PFS Proposed Rule
... -
For Seniors in Rural Communities, Erosion of Lab Benefits is an Urgent Threat
One in four seniors in the United States lives in a rural area—a notable statistic considering the unique set of health challenges these communities face. Nearly 80% of rural America is “medically underserved,” according to the federal government. Seniors living in these parts of the country have far fewer options for care and are often required to travel significant distances just to get theContinue Reading »... -
AIM Coalition Letter of Support for The Promoting Integrity in Medicare Act (PIMA), H.R.2143
... -
ACLA Deeply Concerned by FDA Actions on Pharmacogenetic Testing
Agency actions limit clinical information for physicians and patients, undermine Congress and ongoing diagnostic reform efforts Washington, D.C. – In response to the U.S. Food and Drug Administration (FDA)’s troubling actions against pharmacogenetic (PGx) testing, ACLA urged the agency to immediately reconsider and reverse its recent decisions in light of the significant harm and consequences to patient care. Taken together, FDA’s actions appear toContinue Reading »... -
ACLA Statement in Response to U.S. Court of Appeals Ruling in ACLA v. Azar
Court of Appeals Says ACLA is Entitled to Challenge HHS’s Harmful Regulatory Overreach Washington, D.C. — In response to today’s ruling from the U.S. Court of Appeals for the District of Columbia in favor of the American Clinical Laboratory Association (ACLA) in its lawsuit against the Department of Health and Human Services (HHS), ACLA President Julie Khani issued the following statement: “We strongly commend the CourtContinue Reading »...
